The association between mean arterial pressure and outcomes in patients with cardiogenic shock: insights from the DOREMI trial

Abstract

In patients with CS treated with inotrope therapy, low MAP is associated with worse clinical outcomes. Randomized data evaluating optimal MAP targets in CS is needed to guide medical therapy.